{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:09:25Z","timestamp":1785283765053,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijcard.2018.06.066","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T22:07:59Z","timestamp":1529532479000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Efficacy and adverse effects of sotalol in adults with congenital heart disease"],"prefix":"10.1016","volume":"274","author":[{"given":"Benjamin M.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael L.","family":"Cordina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Celermajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijcard.2018.06.066_bb0005","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.hrthm.2014.05.009","volume":"11","author":"Khairy","year":"2014","journal-title":"Heart Rhythm."},{"issue":"6","key":"10.1016\/j.ijcard.2018.06.066_bb0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/14779072.2014.914434","article-title":"Tachyarrhythmias and catheter ablation in adult congenital heart disease","volume":"12","author":"Chubb","year":"2014","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.ijcard.2018.06.066_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14779072.4.1.83","article-title":"Arrhythmias in adult congenital heart disease","volume":"4","author":"Khairy","year":"2006","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"11","key":"10.1016\/j.ijcard.2018.06.066_bb0020","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/hrt.2009.185595","article-title":"The emerging burden of hospital admissions of adults with congenital heart disease","volume":"96","author":"Verheugt","year":"2010","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ijcard.2018.06.066_bb0025","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","article-title":"Adverse effects of low dose amiodarone: a meta-analysis","volume":"30","author":"Vorperian","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.06.066_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.100.2.149","article-title":"Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease","volume":"100","author":"Thorne","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcard.2018.06.066_bb0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archinte.166.7.719","article-title":"Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials","volume":"166","author":"Lafuente-Lafuente","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2018.06.066_bb0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/europace\/euq450","article-title":"Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation","volume":"13","author":"Freemantle","year":"2011","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.ijcard.2018.06.066_bb0045","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1253\/circj.CJ-08-0194","article-title":"Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease","volume":"72","author":"Miyazaki","year":"2008","journal-title":"Circ. J."},{"issue":"9","key":"10.1016\/j.ijcard.2018.06.066_bb0050","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.amjcard.2013.07.029","article-title":"Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias","volume":"112","author":"Koyak","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2018.06.066_bb0055","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-8703(95)90079-9","article-title":"Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome","volume":"130","author":"Tanel","year":"1995","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2018.06.066_bb0060","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0735-1097(01)01272-4","article-title":"Task force 1: the changing profile of congenital heart disease in adult life","volume":"37","author":"Warnes","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2018.06.066_bb0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"18","key":"10.1016\/j.ijcard.2018.06.066_bb0070","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"11 Pt 2","key":"10.1016\/j.ijcard.2018.06.066_bb0075","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/j.1540-8159.2000.tb07044.x","article-title":"Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?","volume":"23","author":"Kochiadakis","year":"2000","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"24","key":"10.1016\/j.ijcard.2018.06.066_bb0080","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group","volume":"340","author":"Pacifico","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2018.06.066_bb0085","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/0735-1097(95)00268-3","article-title":"Efficacy and proarrhythmia of oral sotalol in pediatric patients","volume":"26","author":"Pfammatter","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2018.06.066_bb0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0002-8703(99)70484-9","article-title":"Sotalol: an important new antiarrhythmic","volume":"137","author":"Anderson","year":"1999","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2018.06.066_bb0095","doi-asserted-by":"crossref","first-page":"74A","DOI":"10.1016\/0002-9149(90)90207-H","article-title":"Clinical safety profile of sotalol in patients with arrhythmias","volume":"65","author":"Soyka","year":"1990","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.06.066_bb0100","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.CIR.81.2.686","article-title":"Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence","volume":"81","author":"Hondeghem","year":"1990","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ijcard.2018.06.066_bb0105","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/01.CIR.94.10.2535","article-title":"Sex difference in risk of torsade de pointes with d,l-sotalol","volume":"94","author":"Lehmann","year":"1996","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2018.06.066_bb0110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0022-5223(96)70344-6","article-title":"Staged operation to Fontan increases the incidence of sinoatrial node dysfunction","volume":"111","author":"Manning","year":"1996","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.ijcard.2018.06.066_bb0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4158\/EP13059.OR","article-title":"Amiodarone-induced thyrotoxicosis in adults with congenital heart disease\u2014clinical presentation and response to therapy","volume":"20","author":"Stan","year":"2014","journal-title":"Endocr. Pract."},{"issue":"4","key":"10.1016\/j.ijcard.2018.06.066_bb0120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0735-1097(87)80276-0","article-title":"Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease","volume":"10","author":"Moak","year":"1987","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318324252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318324252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T21:13:56Z","timestamp":1546636436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318324252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":24,"alternative-id":["S0167527318324252"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.066","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and adverse effects of sotalol in adults with congenital heart disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}